Clearside Biomedical Investor Relations Material
Latest events
Q4 2023
Clearside Biomedical
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Clearside Biomedical Inc
Access all reports
Clearside Biomedical, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of therapies for choroideremia and other eye diseases. The company focuses on revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space using its proprietary Transcutaneous Delivery System, or "TDS". The company's portfolio contain several patented therapies.
Latest articles
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States